Gastric ulcer in a child treated with deferasirox
- 176 Downloads
We present a patient with thalassemia major who developed a gastric ulcer, probably related to the use of deferasirox. Although gastric ulcer is mentioned as infrequent adverse event in the scientific product information of deferasirox, in our current knowledge, this is the first case-report on this adverse drug reaction. The severity of this event justifies the reporting of this case.
KeywordsCase report Deferasirox Gastric ulcer Haematemesis Pediatrics Haemato-oncology
Conflicts of interest
The authors have no conflicts of interest.
- 5.Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, et al. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006;107(9):3455–62.Google Scholar
- 7.Scientific Leaflet Deferasirox (in Flemish). http://www.ecompendium.be/. Accessed 3 August 2009.
- 8.Scientific Leaflet Folic Acid (in Flemish). http://www.ecompendium.be/. Accessed 3 August 2009.
- 9.Identifying Adverse Drug Reactions. http://mqa.dhs.state.tx.us/QMWeb/MedSim/Naranjo.htm. Accessed 14 April 2009.